Lavie Bio
Microbiome-based Products for Improved Food Quality
Startup Acquired Agriculture & Food Technologies Est. 2019
Total Raised
$37M
Acquired
Last Round
Undisclosed
3 rounds
Investors
2
2 public
Team
5
11-50 employees
Confidence
100/100
News
17
articles
Patents
1
About
Lavie Bio aims to improve food quality, health, and agricultural sustainability through the introduction of microbiome-based agriculturalbiological products. Utilizing proprietary computational predictive technologies, Lavie Bio is developing biostimulants and biopesticides and is engaged in an ongoing collaboration with Corteva for the development of corn biostimulants. Lavie Bio is a subsidiary of Evogene Ltd.
Classification
Sector
Climate TechFood & Land UseSustainable FarmingAgriculture & Food TechnologiesAg TechFarm Equipment & TreatmentGenetics & Input
Core Technology
BiologicalsMicroorganisms
Target Customer
Agriculture & FoodCrops
Business Model
B2B
Tags
fungicidesclimate-techpesticidesbiotechnologyagtechmicrobiomeplasticsplant-protectioncropsagriculture
Funding & Events
Sep 2024
Non-equity Undisclosed
Israel Innovation Authority
Aug 2022
Convertible Debt $10M
ICL Planet Startup Hub
Aug 2019
A Round $27M
Corteva
Apr 2025
Exit Undisclosed
News (17)
Aug 19, 2025 · www.prnewswire.com
growth-positive
Conference call and webcast: today, August 19, 2025, 9:00 am ET Financial Highlights: The financial results for the first half of 2025 of Lavie Bio, a...
AcquisitionInvestmentLayoffsPartnersCustomers
Jul 8, 2025 · www.prnewswire.com
growth-positive
/PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a leading computational biology company utilizing cutting-edge artificial intelligence and predictive...
Acquired-byAcquisition
Apr 21, 2025 · www.prnewswire.com
growth-positive
/PRNewswire/ -- Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN) a leading computational biology company focused on revolutionizing life-science-based product...
Acquired-byPartners
Sep 30, 2024 · www.prnewswire.com
growth-positive
/PRNewswire/ -- Lavie Bio Ltd., a leading ag-biologicals company and a subsidiary of Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), announced receiving a grant from...
Investment
Sep 30, 2024 · www.prnewswire.com
growth-positive
Lavie Bio Receives Grant from Israel Innovation Authority to Advance the Development of 'MicroFermentor', a Unique Technology that Can Change the Economics of Ag-Biologicals
Investment
Jul 17, 2024 · www.prnewswire.com
growth-positive
ICL and Lavie Bio Leverage Artificial Intelligence to Make Significant Advancement in Development of Yield Increasing Bio-Stimulants
PartnersExpand
Feb 28, 2024 · www.prnewswire.com
growth-positive
Lavie Bio Successfully Secures Second Half Advance Payment of $2.5M after Meeting Corteva's Licensing Agreement Requirements
CustomersPartners
Feb 20, 2024 · www.prnewswire.com
growth-positive
Syngenta and Lavie Bio Announce Partnership to Discover and Develop Novel Bio-Insecticide
Partners
Jul 17, 2023 · lavie-bio.com
growth-positive
Lavie Bio Announces Licensing Agreement for Bio-Fungicides with Corteva Agriscience - Lavie Bio
Partners
Oct 12, 2022 · www.prnewswire.com
growth-positive
Lavie Bio Advances its Novel Bio-fungicide Program and Applies to the U.S. EPA for Regulatory Approval
Investment
Aug 16, 2022 · ca.movies.yahoo.com
ICL and Lavie Bio Enter Strategic Collaboration to Develop Novel Bio-Stimulant Products
Dec 14, 2021 · www.prnewswire.com
growth-positive
Lavie Bio Reports Advancement in its Bio-Fungicide Program for Fruit Rots
InvestmentPartners
Sep 29, 2021 · www.prnewswire.com
growth-positive
Lavie Bio and United Agronomy Announce Signing of Distribution Agreement for Lavie Bio's Inoculant Product
Partners
Dec 29, 2020 · www.prnewswire.com
growth-positive
Lavie Bio Provides Product Pipeline Update for 2020
InvestmentPartners
Nov 18, 2019 · www.prnewswire.com
growth-positive
Lavie Bio Announces Advancement in Its Product Development Pipeline for Wheat Bio-stimulants
CustomersInvestment
Aug 7, 2019 · en.globes.co.il
growth-positive
Corteva invests $10m in Evogene's LaVie Bio unit
Partners
Feb 26, 2019 · www.prnewswire.com
growth-positive
Evogene Announces Establishment of Ag-Biologicals Subsidiary - LaVie Bio Ltd.
PartnersManagement Changes
Details
Product Stage
Released
Employees
11-50
Exact Count
39
District
Center District
Founded
2019
Registrar
515964708
Crunchbase
lavie-bio
Locations
Derech Gad Feinstein 13, Rehovot, Israel
3730 Foundry Way #218, St. Louis, MO 63110, USA
Links
Website
LinkedIn
Twitter
Facebook
Careers
Admin
Last Update
Aug 21, 2025
Verified by
Jenny Sotnik-Talisman
Claimed
Yes
Missing
markets
Team (5)
Amit Noam
CEO
Russ Putland
EVP Commercial & General Manager USA
Dor Kestecher
VP Business Development
Amir Bercovitz
VP Development
Michael Ionescu
VP Research
Internal
Created by
Hilla Gorokhovsky (hilla.gorokhovsky@sncentral.org)
Created
2019-02-27T00:00:00.000Z
Last editor
Ortal Wein (ortalw@sncentral.org)
Status
Acquired by ICL on Apr, 2025